Pharma Buzz
- May22 5:50pmDoc complains, gets “misleading” bus ads promoting screening banned
- May22 5:20pmCompounding Bill Glides Toward Senate Floor; FDA Gets More Flexibility On Fees
- May22 4:35pmMylan: Brand/Generic Distinction Disintegration Is Necessary
- May22 3:05pmStand-Alone Part D Plans Subject To Medical Loss Ratio Checks, CMS Confirms
- May22 2:55pmFinal Assault: Daiichi Sankyo Threatens Legal Action Against Former Ranbaxy Shareholders For Concealing Information
- May22 2:32pmUPDATE: 16 YES VOTES -- We're Monitoring FDA Advisory Committee Meeting On Suvorexant: Unfolding As Expected
- May22 1:50pmIn India, Roche’s Herceptin Strategy Collides With Mylan
- May22 12:59pmCell reviewing allegations of image reuse in human embryonic stem cell cloning paper
- May22 12:11pmUsing Social Media as an Early Predictor of a New Drug's Market Share
- May22 11:52amNew York City Will Speed Plans to Rid Schools of Light Fixtures Containing Toxic PCBs
- May22 11:42amBillionaires snap up former Merck Serono HQ for Geneva biotech hotspot
- May22 11:17amUnderappreciated Analytical Techniques
- May22 10:35amSpecialty drugs to rocket upward by 67% by 2015
- May22 10:22amBoehringer Ingelheim handed FDA warning letter
- May22 10:20amAsia On The Move: Personnel News From Roche, Astellas And Pfizer
- May22 10:17amAmag pulls anemia drug batch after Swiss patient dies
- May22 9:59amOptimal synbiotics – new study unlocks the ideal pre- and probiotic combinations
- May22 9:48amPfizer offers share exchange to grant Zoetis its freedom
- May22 9:30amDoing the right thing: Psychology researchers retract after realizing data “were not analyzed properly”
- May22 9:30amHas Ranbaxy Damaged India’s Pharma Brand?
- May22 8:29amMaternal iodine deficiency could lead to lower IQs, new studies suggest
- May22 7:58amHow Many Binding Pockets Are There?
- May22 7:30amAnother Aredia-Zometa Win, Read Against That Institute You Can't Disparage
- May22 5:57amEFSA sets standard for study rigor, consultant says
- May22 5:17amWarning letter gives look at how FDA views supplement-beverage divide
- May22 4:05amCFDA Announces Overall Plans For Staffing, Internal Structures, Duties
- May22 3:55amChinese City’s Disease Control Center Illegally Tenders For Type II Vaccines
- May22 3:50amCFDA Announces Schedule For E-Monitoring Of New EDL Drugs
- May22 3:20amGSK To Shut Australia Tablet Plant, Shift Operations To Spain, Poland
- May22 3:15amIndia Cancels Plan Of Free Generics At Hospitals, Health Centers
- May22 1:00amWomen Beware: Most Feminine Hygiene Products Contain Toxic Ingredients
- May22 1:00amBayer, Pfizer Accused of Making False Claims About Their Top-Selling Multivitamins
- May21 6:50pmIndia Orders Own Probe Of Ranbaxy's Approved Drugs Backgrounds
- May21 6:40pmJapan Plans Increase In Drug-Review Staff To Speed Approvals
- May21 6:05pmA Trio Of Strategic VCs Helps To Back Effector Therapeutics With $45 Million
- May21 5:55pmEverything REMS Under The Sun: FDA Lays Out Ambitious PDUFA V Meeting Agenda
- May21 5:49pmDebt Deal Closed Last Night; Merck Up 4.7% On Triple Volume Today. Why? Goldman Sachs, That's Why.
- May21 4:50pmKaryopharm Scores $48M Series B To Advance Early Cancer Compounds
- May21 4:24pmSTOP PHARMA’S BACK-ROOM DEALS
- May21 4:20pmDrug Development Needs “Clean-Slate Think” To Involve Patients All Along The Way – Pfizer’s Lewis-Hall
- May21 3:45pmSpicyIP Tidbit: IPXI releases latest edition of its Rulebook.
- May21 3:10pmBothering To Look: With New Tools, Biotech Goes Back To The Black Box
- May21 3:00pm“Ephemeral nature” of samples — and co-author — leads to ninth Jesús Lemus retraction
- May21 2:55pmNorway’s Xellia Pharma Acquired By Novo A/S In $700 Million Buyout
- May21 2:00pmDrug Discovery, Step By Step
- May21 1:27pmJerome "The Bus" Bettis Promotes Auvi-Q With and Without the Important Safety Information
- May21 1:24pmPlaintiff’s Second Try Still Preempted
- May21 1:20pmAstraZeneca Shakeup Of China Business Unit Steers Focus Away From Generics To Innovative Drugs
- May21 1:00pmMedWatch’s Patient-friendly Reporting Form Might Need An Overhaul
- May21 12:59pmIMRT for prostate cancer: newer, costlier radiation no better than old
